CollPlant Biotechnologies (CLGN) EBITDA Margin Growth (5y) (2022 - 2025)
CollPlant Biotechnologies (CLGN) EBITDA Margin Growth (5y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -515,873.00 |
| Sep 30, 2025 | -457,224.00 |
| Jun 30, 2025 | 200,786.00 |
| Mar 31, 2025 | 36,049.00 |
| Dec 31, 2024 | -342,431.00 |
| Sep 30, 2024 | -11.40 Mn |
| Jun 30, 2024 | 151,865.00 |
| Mar 31, 2024 | 407,425.00 |
| Dec 31, 2023 | -173,039.00 |
| Sep 30, 2023 | -57,992.00 |
| Jun 30, 2023 | -88,876.00 |
| Mar 31, 2023 | -18,063.00 |
| Dec 31, 2022 | -868,171.00 |